BDR Pharmaceuticals plans $100 mn expansion in the US with manufacturing buyouts

BDR Pharmaceuticals is set to broaden its presence in the US through acquisitions of manufacturing facilities, backed by a $100 million investment. Chairman Dharmesh Shah mentioned the company is evaluating potential units and expects a decision within months, funded by internal accruals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cK9xTlR
via IFTTT